Nuclear protein in testis carcinoma of the mediastinum: a case report

J Med Case Rep. 2017 Jun 9;11(1):152. doi: 10.1186/s13256-017-1328-x.

Abstract

Background: Nuclear protein in testis carcinoma is a rare and very aggressive undifferentiated cancer which characteristically arises in the midline of the head, neck, and mediastinum.

Case presentation: We describe the case of a 46-year-old white woman admitted for superior vena cava syndrome revealing a mediastinal tumor. Pathological examination of specimens obtained by mediastinoscopy revealed an undifferentiated tumor with solid growth and positive immunoreactivity for p40 and negative immunoreactivity for cytokeratin markers. Immunohistochemical staining was positive for nuclear protein in testis, allowing the diagnosis of nuclear protein in testis midline carcinoma of the mediastinum.

Conclusions: We present a rare case of mediastinal nuclear protein in testis carcinoma with diagnosis based on nuclear protein in testis protein positivity and atypical immunohistochemical features including p40 positivity and anti-cytokeratin negativity. Physicians must remain aware of the possibility of nuclear protein in testis carcinoma especially in young patients with thoracic symptoms and suspicion of neoplasm.

Keywords: Mediastinal neoplasms; NUT carcinoma; Superior vena cava syndrome.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Biomarkers, Tumor / genetics
  • Fatal Outcome
  • Female
  • Humans
  • Immunohistochemistry
  • Mediastinal Neoplasms / diagnosis*
  • Mediastinal Neoplasms / genetics*
  • Mediastinal Neoplasms / physiopathology
  • Mediastinal Neoplasms / therapy
  • Middle Aged
  • Nuclear Proteins / genetics*
  • Oncogene Proteins, Fusion / genetics*
  • Rare Diseases
  • Recurrence
  • Superior Vena Cava Syndrome / diagnosis*
  • Superior Vena Cava Syndrome / physiopathology

Substances

  • Antineoplastic Agents
  • BRD4-NUT fusion oncogene protein, human
  • Biomarkers, Tumor
  • Nuclear Proteins
  • Oncogene Proteins, Fusion